XK
EW icon

Xact Kapitalforvaltning’s Edwards Lifesciences EW Stock Holding History

Xact Kapitalforvaltning’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-124,062
Closed -$7.91M – 1451
2019
Q1 		$7.91M Buy
124,062
+11,850
+11% +$676K 0.18% 108
2018
Q4 		$5.73M Sell
112,212
-5,172
-4% -$262K 0.15% 137
2018
Q3 		$6.81M Sell
117,384
-8,670
-7% -$424K 0.14% 140
2018
Q2 		$6.12M Buy
126,054
+3,252
+3% +$152K 0.13% 153
2018
Q1 		$5.71M Buy
122,802
+5,769
+5% +$251K 0.13% 164
2017
Q4 		$4.4M Buy
117,033
+20,544
+21% +$754K 0.11% 202
2017
Q3 		$3.52M Buy
96,489
+699
+0.7% +$26.7K 0.1% 220
2017
Q2 		$3.77M Sell
95,790
-156
-0.2% -$5.69K 0.11% 202
2017
Q1 		$3.01M Buy
95,946
+5,025
+6% +$157K 0.09% 247
2016
Q4 		$2.84M Buy
90,921
+3,678
+4% +$119K 0.1% 233
2016
Q3 		$3.51M Buy
+87,243
New +$3.29M 0.12% 191

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Xact Kapitalforvaltning's EW Position: Q2 2019 in Review

Xact Kapitalforvaltning sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 124,062 shares — an estimated $7.91M sold.

Xact Kapitalforvaltning first reported a position in EW in Q3 2016 and held it in 11 quarters. The position peaked at $7.91M in Q1 2019. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

  • Xact Kapitalforvaltning reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
  • Xact Kapitalforvaltning sold 124,062 Edwards Lifesciences shares in Q2 2019, an estimated $7.91M.
  • Xact Kapitalforvaltning first reported a position in Edwards Lifesciences in Q3 2016 and held it in 11 quarters.
  • Xact Kapitalforvaltning's Edwards Lifesciences position peaked at $7.91M in Q1 2019.
  • 921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on Xact Kapitalforvaltning's 13F filing for Q2 2019, filed 12 Jul 2019.